REN and diabetes mellitus: In this study we have employed transgenic mice with the human renin cDNA under the control of the transthyretin promoter (TTRhRen) and induced diabetes either through streptozotocin (STZ)-injections or by crossing with the OVE26 transgenic type 1 diabetes mouse on the susceptible FVB/n background.